References
- Thomalley P. J., Dodd N. J.F. Free radical production from normal and adriamycin-treated rat cardiac sarcosomes. Biochemical Pharmacology 1985; 34: 669–674
- Nohl H. Identification of the site of adriamycin activation in the heart cell. Biochemical Pharmacology 1988; 37: 2633–2637
- Myers C. E. Role of iron in anthracycline action. Organ directed toxicity of anticancer drugs, M. P. Hacker, J. S. Lazo, T. R. Tritton. Martinus Nijhoff Publ., Boston 1988; 17–30
- Singal P. K., Deally C. M.R., Weinberg L. E. Subcellular effects of adriamycin in the heart: a concise review. Journal of Molecular and Cellular Cardiology 1987; 19: 817–827
- Griffin-Green E. A., Zaleska M. M., Erecinska M. Adriamycin-induced lipid peroxidation in mitochondria and microsomes. Biochemical Pharmacology 1988; 37: 3071–3077
- Burton K. P., McCord J. M., Ghai G. Myocardial alterations due to free radical generation. American Journal of Physiology 1984; 246: H776–783
- Burton K. P. Evidence of direct toxic effects of free radicals on the myocardium. Free Radical Biology and Medicine 1988; 4: 15–24
- Blaustein A. S., Schine L., Brooks W. W., Fanburg B. L., Eing O. H.L. Influence of exoge-nously-generated oxidant species on myocardial function. American Journal of Physiology 1886; 250: H595–599
- Jackson C. V., Mickelson J., Pope T. K., Rao P. S., Lucchesi B. R. Oxygen free radical-mediated myocardium and vascular dysfunction. American Journal of Physiology 1986; 251: H1225–1231
- Villani F., Galimberti M., Monti E., Piccinini F., Lanza E., Rozza A., Favalli L., Poggi P., Zunino F. Effect of glutathione and N-acetylcysteine on in vitro and in vivo cardiac toxicity of doxorubicin. Free Radical Research Communications 1990; 11: 145–151
- Monti E., Paracchini L., Perlettiand G., Piccinini F. Protective effects of spin trapping agents on adriamycin-induced cardiotoxicity in isolated rat atria. Free Radical Research Communications 1991; 14: 41–45
- Cova D., DeAngelis L., Monti E., Piccinini F. Subcellular distribution of two spin trapping agents in rat heart: possible explanation for their different protective effects against doxorubicin-in-duced cardiotoxicity. Free Radical Research Communications 1992; 15: 353–360
- Jotti A., Paracchini L., Perletti G., Piccinini F. Cardiotoxicity induced by doxorubicin in vivo: protective activity of the spin trap alpha-phenyl-tert-butyl nitrone. Pharmacological Research 1992; 26: 143–150
- Janzen E. G., Zhang Y-K, Haire D. L. Synthesis of a novel nitrone, 2-phenyl-5,5-dimethyl-1-pyrroiine-N-oxide-nitronyl-13C for enhanced radical addend recognition and spin adduct persistence. Journal of the American Chemical Society 1994; 116: 3738–3743
- Villani F., Monti E., Piccinini F., Favalli L., Lanza E., Rozza A., Poggi P. Relationship between ECG changes and myocardial morphological alterations induced by adriamycin in rat. Tumori 1986; 72: 339–344
- Paracchini L., Jotti A., Bottiroli G., Prosperi E., Supino R., Piccinini F. The spin trap alpha-phenyl-tert-butyl nitrone protects against myelotoxicity and cardiotoxicity of adriamycin while preserving the cytotoxic activity. Anticancer Research 1993; 13: 1607–1612
- Monti E., Piccinini F., Villani F., Favaili L. Myocardial contractility and heart pharmacokinetics of adriamycin following a single administration in the rat. Cancer Chemotherapy Pharmacology 1986; 18: 289–291
- Chen B., Bray T. M., Janzen E. G., McCay P. B. Excretion metabolism and tissue distribution of a spin trapping agent, alpha–phenyl-tert-butyl nitrone (PBN) in rats. Free Radical Research Communications 1990; 9: 317–323
- Bradamante S., Jotti A., Paracchini L., Monti E. The hydrophilic spin trap, 5,5-dimethyl-l-pyrroline-1-oxide, does not protect the rat heart from reperfusion injury. European Journal of Pharmacology 1993; 234: 113–116
- Bradamante S., Monti E., Paracchini L., Lazzarini E., Piccinini F. Protective activity of the spin trap tert-butyl-alpha-phenyl nitrone (PBN) in reperfused heart. Journal of Molecular and Cellular Cardiology 1992; 24: 375–386